Search

Your search keyword '"Winsel K"' showing total 54 results

Search Constraints

Start Over You searched for: Author "Winsel K" Remove constraint Author: "Winsel K" Database MEDLINE Remove constraint Database: MEDLINE
54 results on '"Winsel K"'

Search Results

1. Novel method and parameters for testing and characterization of foam stability.

2. Quantitative Brewster angle microscopy of the surface film of human broncho-alveolar lavage fluid.

3. [Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways].

4. [The antioxidative and inflammation inhibiting properties of ambroxol].

5. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].

6. [Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count].

7. [Clinical pharmacology in optimization of therapy of lung diseases].

8. [Chemiluminescence measurements of bronchoalveolar lavage cells in patients with collagenosis].

9. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.

10. Application of bromhexine metabolite VIII (NA 872) and bromhexine-glucose in treatment of adult respiratory distress syndrome; experimental and clinical results .

11. Gas exchange, pulmonary mechanics and haemodynamics in adult respiratory distress syndrome: experimental results in Lewe miniature pigs.

12. Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome.

14. [Morphological demonstration of phospholipids in the lung (author's transl)].

15. [The effect of ambroxol and bromhexine on the "respiratory burst" of alveolar macrophages].

16. [The lipids of the lungs in experimental aspiration pneumonitis (author's transl)].

17. [Function, composition, biosynthesis and degradation of the surfactant system (anti-atelectasis factor) of the lung].

18. [Clinico-experimental studies of therapy optimization in kidney tuberculosis].

19. [Tracheal instillation of arachidonic acid as an asthma model in guinea pigs--preliminary results of the effect of inhibitors of arachidonic acid metabolism].

20. [Bronchoalveolar lavage].

21. [Ultrastructural and autoradiographical investigations of early changes in experimental lung fibrosis (author's transl)].

22. [Article in addition of the differentiated diagnostics of chylous pleural effusions (author's transl)].

23. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].

24. [Quantitative determination of alpha1-antitrypsin in lung tissue from adults with emphysema and newborns with respiratory-distress-syndrome (author's transl)].

26. [Experimental respiratory distress syndrome after injection anti-pulmonary serum. III. Respiratory-mechanical, blood gas-analysis, physico-chemical and biochemical findings in chronic tests: attempts at therapy].

28. [Extracorporeal lung perfusion in experimental canine lung transplantation (author's transl)].

29. [Changes of biochemical processes of the lungs caused by air pollutants (author's transl)].

30. [Functional analysis in experimental respiratory distress syndrome (author's transl)].

31. [Results of studies on dogs after unilateral allogeneic lung transplantation without immunosuppression].

33. [The appearance of surface-active phospholipids of the surfactant-system of the lung during ontogenetic development of humans (author's transl)].

34. [Damage factors in tobacco and tobacco smoke].

35. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.

36. [Short scientific report. Vitamin C lessens superoxide anion(O2)-induced bronchial constriction].

37. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].

38. [Liposomes from hydrogenated egg yolk lecithin].

40. Failure of ambroxol to influence the allergen induced bronchial constriction in sensitized guinea pigs.

41. On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patients.

42. [Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid].

43. [Chemiluminescent measurements of alveolar macrophages in sarcoidosis patients].

44. [Morphological studies of experimental lung transplantation. I. Light microscopic and histochemical findings in autotransplants of dog lungs].

45. [Effect of antioxidants on the production of reactive oxygen metabolites by stimulated alveolar macrophages].

46. [The different inactivation of isoniazid in intermittent chemotherapy (author's transl)].

47. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.

49. Experimental investigations in adult respiratory distress syndrome (ARDS). Repeated pulmonary lavage in LEWE-mini-pigs. I. Pulmonary mechanics, gas exchange, and pulmonary hemodynamics.

50. [The anti-atelectasis factor of the lung. I].

Catalog

Books, media, physical & digital resources